CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank83
Studio
Year-over-Year Change

Price-to-book ratio

Latest
5.93
↑ 107% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive growthElevated
Average
-80.40
Historical baseline
PeriodValueYoY Change
20255.93+103.1%
2024-190.73-7810.2%
2023-2.41-96.6%
2022-1.23+99.8%
2021-605.13-1456.4%
2020-38.88-627.5%
20197.37+53.3%
20184.81-57.2%
201711.23+121.2%
20165.07-